Nested supramolecular capsules

US10189955B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10189955-B2
Application numberUS-201414763071-A
CountryUS
Kind codeB2
Filing dateJan 30, 2014
Priority dateJan 30, 2013
Publication dateJan 29, 2019
Grant dateJan 29, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A nested capsule having a first capsule held within a second capsule. Each of the first and second capsules has a shell that is a supramolecular cross-linked network, such as a cucurbituril supramolecular cross-linked network. Each capsule shell is obtained or is obtainable from the complexation of a composition including a host, such as cucurbituril, and one or more building blocks having suitable guest functionality for the host, thereby to form a supramolecular cross-linked network. The nested capsules are suitable for delivering and selectively releasing an encapsulant at a location.

First claim

Opening claim text (preview).

The invention claimed is: 1. A nested capsule comprising a first capsule held within a second capsule, and each of the first and second capsules has a shell that is a supramolecular cross-linked network, wherein each shell is obtainable from the complexation of a composition comprising a host and one or more building blocks having suitable guest functionality, thereby to form a supramolecular cross-linked network, wherein the second capsule is not provided as a layer on the surface of the first capsule, and the supramolecular cross-linked network includes a non-covalent complex of the host and the one or more building blocks having suitable guest functionality. 2. The nested capsule according to claim 1 , wherein the host is selected from cucurbituril, cyclodextrin, calix[n]arene, and crown ether compounds, and the one or more building blocks having suitable guest functionality for the cucurbituril, cyclodextrin, calix[n]arene, and crown ether hosts. 3. The nested capsule according to claim 2 , wherein the host is a cucurbituril compound, and the one or more building blocks having suitable cucurbituril guest functionality. 4. The nested capsule according to claim 3 , wherein the host is CB[8]. 5. The nested capsule according to claim 1 , wherein the shell of the first capsule is different to the shell of the second capsule. 6. The nested capsule according to claim 5 , wherein a building block present in the shell of the first capsule is not present in the shell of the second capsule. 7. The nested capsule according to claim 1 , wherein each capsule shell is obtainable from the complexation of (a) a composition comprising a host and (1) or (2); or (b) a composition comprising a plurality of covalently linked hosts and (1), (2) or (3), wherein: (1) comprises a first building block covalently linked to a plurality of first guest molecules and a second building block covalently linked to a plurality of second guest molecules, wherein a first guest molecule and a second guest molecule together with the host are suitable for forming a ternary guest-host complex; (2) comprises a first building block covalently linked to a plurality of first guest molecules and a plurality of second guest molecules, wherein a first and a second guest molecule together with the host are suitable for forming a ternary guest-host complex, optionally the composition further comprises a second building block covalently linked to one or more third guest molecules, one or more fourth guest molecules or both, wherein a third and a fourth molecule together with the host are suitable for forming a ternary guest-host complex, and/or the first and fourth molecules together with the host are suitable for forming a ternary guest-host complex, and/or the second and third molecules together with the host are suitable for forming a ternary guest-host complex; (3) comprises a first building block covalently linked to a plurality of first guest molecules, wherein the first guest molecule together with the host are suitable for forming a binary guest-host complex. 8. The nested capsule according to claim 7 , wherein each capsule shell is obtainable from the complexation of a composition comprising a host and (1) or (2). 9. The nested capsule according to claim 1 , wherein one of the first and second capsules has a building block that is anionic, and the other of first and second capsules has a building block that is cationic. 10. The nested capsule according to claim 1 , wherein one of the first and second capsules has two anionic building blocks. 11. The nested capsule according to claim 1 , wherein one of the first and second capsules has two cationic building blocks. 12. The nested capsule according to claim 1 , wherein the each of the first and second capsules has a building block that is a polymeric molecule. 13. A nested capsule according to claim 1 , wherein the nested capsule holds an encapsulant. 14. The nested capsule according to claim 13 , wherein the first capsule holds a first encapsulant and the second capsule holds a second encapsulant. 15. The nested capsule according to claim 14 , wherein the first encapsulant is different to the second encapsulant. 16. The nested capsule according to claim 13 , wherein the nested capsule holds an encapsulant that is a biomolecule. 17. The nested capsule according to claim 16 , wherein the biomolecule has a detectable label. 18. A method of delivering an encapsulant to a location, the method comprising the steps of: (i) providing a nested capsule according to claim 13 ; (ii) delivering the nested capsule to a location; and (iii) permitting release of the encapsulated encapsulant from the nested capsule at the location. 19. The method of claim 18 , wherein the encapsulant is held in the first capsule or the second capsule or both. 20. A method of delivering a plurality of encapsulants to one or more locations, the method comprising the steps of: (i) providing a nested capsule according to claim 14 ; (ii) delivering the nested capsule to a location; (iii) permitting release of the second encapsulant from the second capsule at a first location; and (iv) subsequently permitting release of the first encapsulant from the first capsule at the first location or a second location. 21. A method of delivering a plurality of encapsulants to a location, the method comprising the steps of: (i) providing a nested capsule according to claim 14 ; (ii) delivering the nested capsule to a location; and (iii) permitting release of the second encapsulant from the second capsule at a first location and simultaneously permitting release of the first encapsulant from the first capsule, thereby to deliver the first and second encapsulants to the location. 22. A method of synthesis, the method comprising the steps of: (i) providing a nested capsule according to claim 14 , wherein the first and second encapsulants are interactable; (ii) permitting release of the first encapsulant from the first capsule into the second capsule, thereby to permit the first encapsulant to interact with the second encapsulant to yield a product; and (iii) optionally permitting the release of the product from the second capsule. 23. A method for the preparation of a nested capsule according to claim 1 , the method comprising the steps of: (i) providing a first capsule, wherein the first capsule has a shell that is a supramolecular cross-linked network; (ii) encapsulating the first capsule within a shell of a second capsule, wherein the shell of the second capsule is a supramolecular cross-linked network, thereby to form a nested capsule. 24. A method for the preparation of a nested capsule according to claim 1 , the method comprising the steps of: (i) providing a first droplet within a second droplet, wherein each of the first and second droplets has at its interface components suitable for forming a shell that is a supramolecular cross-linked network; (ii) permitting the components of the first and the second droplet to form a supramolecular cross-linked network, thereby to form a nested capsule. 25. The nested capsule according to claim 1 , wherein each shell is a covalently cross-linked network, wherein the network is obtainable from the supramolecular cross-linked network by the ternary complexation of the composition comprising the host and one or more building blocks having suitable guest functionality, thereby to form the supr

Assignees

Inventors

Classifications

  • containing an anthracene dye · CPC title

  • Coating · CPC title

  • Solid-walled microcapsule from synthetic polymer · CPC title

  • characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release (capsules filled with granules or microparticles A61K9/16; filled with microcapsules or coated microparticles A61K9/50; with mixture of different granules, microcapsules, (coated) microparticles A61K9/5084) · CPC title

  • Interfacial polymerisation · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10189955B2 cover?
A nested capsule having a first capsule held within a second capsule. Each of the first and second capsules has a shell that is a supramolecular cross-linked network, such as a cucurbituril supramolecular cross-linked network. Each capsule shell is obtained or is obtainable from the complexation of a composition including a host, such as cucurbituril, and one or more building blocks having suit…
Who is the assignee on this patent?
Cambridge Entpr Ltd
What technology area does this patent fall under?
Primary CPC classification C08G83/008. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).